Publication | Closed Access

Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels

Metabolic SyndromeOxysterolHypercholesterolemic PatientsCardiovascular DiseaseBiochemistryPharmacologyExtended-release GemfibrozilHyperlipidemiaVascular BiologyLipoprotein MetabolismMedicinePlasma LipoproteinsAtherosclerosisDyslipidemiaOxidative Stress